Anti-SARS Nucleocapsid Protein antibody [6H3]
0
(1 Review)
|
(11 Publications)
Mouse Monoclonal NCAP antibody. Carrier free. Suitable for ICC/IF, IP, WB, sELISA and reacts with SARS-CoV-2, SARS-CoV, Recombinant full length protein - SARS-CoV-2 samples. Cited in 11 publications. Immunogen corresponding to Recombinant Fragment Protein within SARS-CoV N aa 100 to C-terminus.
View Alternative Names
9a, N, Nucleoprotein, Nucleocapsid protein, NC, Protein N
- IP
Supplier Data
Immunoprecipitation - Anti-SARS Nucleocapsid Protein antibody [6H3] (AB273434)
SARS Nucleocapsid Protein was immunoprecipitated from 2μg of SARS-CoV2 Nucleocapsid Protein transfected HEK-293T whole cell lysate with either ab273434 (Lane 3) or a control IgG (Lane 2).
Western blot was performed from the immunoprecipitate using ab273434. An
HRP-conjugated anti mouse IgG antibody, was used as secondary antibody.
All lanes:
Immunoprecipitation - Anti-SARS Nucleocapsid Protein antibody [6H3] (ab273434)
Predicted band size: 46 kDa
false
- sELISA
Supplier Data
Sandwich ELISA - Anti-SARS Nucleocapsid Protein antibody [6H3] (AB273434)
Sandwich ELISA detection of recombinant full-length SARS-CoV-2 nucleocapsid protein using a different anti-SARS-CoV-2 capture antibody at concentration of 5 μg/mL and ab273434 as detection antibody at concentration of 1 μg/mL. Mouse IgG antibody (HRP) was used at 1/10000 to detect the primary antibody.
- WB
Supplier Data
Western blot - Anti-SARS Nucleocapsid Protein antibody [6H3] (AB273434)
10% SDS-PAGE
All lanes:
Western blot - Anti-SARS Nucleocapsid Protein antibody [6H3] (ab273434) at 1/5000 dilution
Lane 1:
Non-transfected HEK-293T cells at 30 µg
Lane 2:
SARS-CoV NP transfected HEK-293T cells at 30 µg
Lane 3:
SARS-CoV2 (COVID-19) NP transfected HEK-293T cells
Lane 4:
MERS-CoV NP transfected HEK-293T cells at 30 µg
Predicted band size: 46 kDa
false
- WB
Supplier Data
Western blot - Anti-SARS Nucleocapsid Protein antibody [6H3] (AB273434)
12% SDS-PAGE
All lanes:
Western blot - Anti-SARS Nucleocapsid Protein antibody [6H3] (ab273434) at 1/5000 dilution
All lanes:
SARS-CoV-2 (COVID-19) nucleocapsid protein at 0.5 µg
Secondary
All lanes:
HRP-conjugated anti-Mouse IgG
Predicted band size: 46 kDa
false
- WB
Supplier Data
Western blot - Anti-SARS Nucleocapsid Protein antibody [6H3] (AB273434)
Vero E6 cells were analysed at the indicated time-points post-infection with SARS-CoV.
All lanes:
Western blot - Anti-SARS Nucleocapsid Protein antibody [6H3] (ab273434)
Lane 1:
SARS-CoV infected Vero E6 cells post infection after 0 hours
Lane 2:
SARS-CoV infected Vero E6 cells post infection after 8 hours
Lane 3:
SARS-CoV infected Vero E6 cells post infection after 16 hours
Lane 4:
SARS-CoV infected Vero E6 cells post infection after 24 hours
Predicted band size: 46 kDa
false
- WB
Supplier Data
Western blot - Anti-SARS Nucleocapsid Protein antibody [6H3] (AB273434)
10% SDS-PAGE
All lanes:
Western blot - Anti-SARS Nucleocapsid Protein antibody [6H3] (ab273434) at 1/5000 dilution
Lane 1:
Non-transfected HEK-293T whole cell extract at 30 µg
Lane 2:
Transfected HEK-293T whole cell extract at 30 µg
Secondary
All lanes:
HRP-conjugated anti-Mouse IgG
Predicted band size: 46 kDa
false
- WB
Supplier Data
Western blot - Anti-SARS Nucleocapsid Protein antibody [6H3] (AB273434)
Cell lysates were analysed by WB 48 hours post-infection with SARS-CoV or SARS Cov-2 at a MOI of 0.01.
Lanes 1 - 2:
Western blot - Anti-SARS Nucleocapsid Protein antibody [6H3] (ab273434) at 1/1000 dilution
Lane 3:
Western blot - Anti-SARS Nucleocapsid Protein antibody [6H3] (ab273434)
Lane 1:
Non-infected Caco-2 whole cell extract
Lane 2:
SARS-CoV infected Caco-2 whole cell extract
Lane 3:
SARS-CoV-2 infected Caco-2 whole cell extract
Predicted band size: 46 kDa
false
- WB
Supplier Data
Western blot - Anti-SARS Nucleocapsid Protein antibody [6H3] (AB273434)
12% SDS-PAGE
All lanes:
Western blot - Anti-SARS Nucleocapsid Protein antibody [6H3] (ab273434) at 1/5000 dilution
Lane 1:
Non-transfected HEK-293T whole cell extract at 30 µg
Lane 2:
SARS-CoV nucleocapsid-transfected (a partial fragment) HEK-293T whole cell extracts at 30 µg
Predicted band size: 46 kDa
false
Reactivity data
Product details
Applications overview
Tick: Tested and Guaranteed to work X: Will not work —: No data
<img src="https://www.abcam.com/ps/Products/273/ab273434/Images/ab273434-394505-ab273434-applications-overview.jpg" height="125" width="675">
Properties and storage information
Form
Purification technique
Purification notes
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
The nucleocapsid protein of SARS-CoV-2 interacts directly with other viral components and host cellular machinery to orchestrate efficient viral assembly and release. It forms a ribonucleoprotein complex by self-association and binding to the RNA genome promoting virion integrity. This protein also plays a part in modulating host cell responses potentially by interfering with antiviral signaling pathways ensuring that the virus evades the host immune system to some degree.
Pathways
Many scientific studies show that the SARS-CoV-2 nucleocapsid protein is involved in the viral replication and assembly pathways. It interacts with viral proteins such as the membrane (M) protein and possibly others to facilitate these processes. The protein also exhibits connectivity with cellular pathways related to RNA processing and metabolism due to its RNA-binding capabilities further influencing viral replication efficiency and host-pathogen interactions.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (11)
Recent publications for all applications. Explore the full list and refine your search
Journal of extracellular vesicles 13:e70001 PubMed39558820
2024
Applications
Unspecified application
Species
Unspecified reactive species
Cell reports. Medicine 4:101079 PubMed37327781
2023
Applications
Unspecified application
Species
Unspecified reactive species
Proceedings of the National Academy of Sciences of the United States of America 119:e2200592119 PubMed35858386
2022
Applications
Unspecified application
Species
Unspecified reactive species
Journal of virology 96:e0000222 PubMed35107372
2022
Applications
Unspecified application
Species
Unspecified reactive species
Veterinary pathology 59:602-612 PubMed35094625
2022
Applications
Unspecified application
Species
Unspecified reactive species
Cellular & molecular immunology 19:210-221 PubMed34983944
2022
Applications
Unspecified application
Species
Unspecified reactive species
Cell 184:6022-6036.e18 PubMed34838159
2021
Applications
Unspecified application
Species
Unspecified reactive species
Clinical journal of the American Society of Nephrology : CJASN 16:1755-1765 PubMed34127485
2021
Applications
Unspecified application
Species
Unspecified reactive species
Nature communications 12:2506 PubMed33947851
2021
Applications
Unspecified application
Species
Unspecified reactive species
Frontiers in immunology 12:661052 PubMed33995382
2021
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com